Profile data is unavailable for this security.
About the company
Paul Hartmann AG is a Germany-based holding company that is principally engaged in the field of medical and healthcare products. The Company operates through four segments, namely Wound Management, Incontinence Management, Infection Management and Other Group Activities. The Wound Management segment comprises wound dressings, as well as products for compression treatment, immobilization, First Aid and diagnostic devices. The Incontinence Management segment includes absorbent products worn close to the body for incontinence hygiene, such as under pads for patients as well as patient hygiene products and medical skin care. The Infection Management segment covers a range of custom procedure trays, surgical draping systems, surgical clothing, and surgical and examination gloves as well as the disinfection assortment. The Other Group Activities includes activities in cotton-wool products, feminine hygiene, baby care, medical consumer goods and pharmaceutical products, among others.
- Revenue in EUR (TTM)2.38bn
- Net income in EUR59.53m
- Incorporated1912
- Employees10.05k
- LocationPaul Hartmann AGPaul-Hartmann-Strasse 12HEIDENHEIM 89522GermanyDEU
- Phone+49 7321360
- Fax+49 7 321363636
- Websitehttps://www.hartmann.info/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| medmix AG | 516.49m | -1.94m | 383.85m | 2.70k | -- | 0.7646 | 6.19 | 0.7432 | -0.05 | -0.05 | 11.35 | 11.30 | 0.4778 | 3.40 | 5.58 | 180,474.00 | -0.0996 | 2.06 | -0.1227 | 2.49 | 32.58 | 36.38 | -0.2085 | 4.16 | 1.06 | 2.21 | 0.4361 | 67.70 | 1.99 | 1.40 | -97.41 | -64.36 | 12.01 | -- |
| Ion Beam Applications SA | 465.75m | 7.85m | 399.73m | 1.84k | 49.10 | 4.27 | 20.39 | 0.8582 | 0.2689 | 0.2689 | 15.99 | 3.09 | 0.7721 | 2.15 | 2.70 | 234,517.10 | 1.30 | 1.55 | 6.01 | 4.32 | 34.19 | 35.23 | 1.69 | 2.38 | 0.6372 | 3.77 | 0.3992 | 64.83 | 18.67 | 10.74 | -250.40 | -- | -8.06 | -- |
| CellaVision AB | 63.63m | 12.97m | 441.60m | 228.00 | 34.06 | 6.66 | 26.67 | 6.94 | 6.30 | 6.30 | 30.91 | 32.19 | 0.7849 | 1.91 | 7.26 | 3,233,162.00 | 15.99 | 15.30 | 18.45 | 18.24 | 66.99 | 69.03 | 20.38 | 19.98 | 2.15 | 1,358.86 | 0.044 | 110.18 | 5.94 | 13.17 | 10.12 | 8.00 | 30.45 | 8.45 |
| RaySearch Laboratories AB (publ) | 100.90m | 15.11m | 458.75m | 414.00 | 39.11 | 8.44 | 12.77 | 4.55 | 5.10 | 5.10 | 34.09 | 23.65 | 0.6023 | 5.51 | 3.29 | 3,005,152.00 | 9.02 | 1.29 | 13.69 | 1.88 | 91.06 | 90.57 | 14.97 | 2.55 | 1.27 | 108.61 | 0.3706 | 69.00 | 21.16 | 10.26 | 243.06 | 0.7648 | -1.31 | -- |
| Advanced Medical Solutions Group plc | 157.58m | 13.38m | 535.28m | 1.50k | 40.09 | 1.83 | 19.83 | 3.40 | 0.051 | 0.051 | 0.6011 | 1.12 | 0.3977 | 1.70 | 4.91 | 154,244.70 | 3.38 | 6.54 | 3.64 | 7.06 | 54.45 | 56.75 | 8.49 | 14.82 | 6.80 | -- | 0.2702 | 25.85 | 1.51 | 4.23 | -22.14 | -6.71 | 15.66 | 12.32 |
| Surgical Science Sweden AB | 74.22m | 16.69m | 643.47m | 270.00 | 38.56 | 1.68 | 29.62 | 8.67 | 3.79 | 3.79 | 16.85 | 87.19 | 0.1769 | 1.56 | 6.80 | 3,307,035.00 | 3.98 | 4.49 | 4.21 | 4.78 | 68.65 | 70.06 | 22.49 | 23.75 | 3.73 | -- | 0.00 | 0.00 | 10.01 | 68.14 | 24.47 | -- | 38.57 | -- |
| Arjo AB (publ) | 965.17m | 44.11m | 720.41m | 6.85k | 17.50 | 1.14 | 5.58 | 0.7464 | 1.88 | 1.88 | 41.05 | 28.87 | 0.7149 | 4.54 | 6.78 | 1,644,896.00 | 3.26 | 3.55 | 4.62 | 5.55 | 43.64 | 44.01 | 4.56 | 5.41 | 0.626 | 3.97 | 0.4073 | 43.01 | 10.03 | 5.97 | 6.90 | 10.15 | -8.89 | 10.35 |
| Medartis Holding AG | 237.18m | 4.34m | 724.59m | 829.00 | 160.30 | 2.47 | 26.30 | 3.06 | 0.3088 | 0.3088 | 17.04 | 20.07 | 0.5377 | 0.5674 | 4.96 | 265,720.50 | 0.9845 | 0.1919 | 1.13 | 0.2153 | 80.53 | 82.33 | 1.83 | 0.3542 | 3.15 | 4.03 | 0.3227 | 0.00 | 15.96 | 11.81 | 110.70 | -31.82 | 5.37 | -- |
| Revenio Group Oyj | 102.08m | 19.01m | 741.20m | 230.00 | 38.56 | 7.30 | 30.56 | 7.26 | 0.7204 | 0.7204 | 3.86 | 3.81 | 0.7834 | 4.93 | 8.17 | 472,574.10 | 14.67 | 14.33 | 17.09 | 17.90 | 49.29 | 50.73 | 18.72 | 21.13 | 1.51 | 34.57 | 0.1276 | 55.81 | -0.4125 | 25.80 | -12.15 | 18.72 | 17.67 | 6.30 |
| Paul Hartmann AG | 2.38bn | 59.53m | 757.35m | 10.05k | 12.77 | 0.6724 | 4.50 | 0.3178 | 16.76 | 16.76 | 671.22 | 318.25 | 1.18 | 1.99 | 5.45 | 234,407.10 | 3.19 | 3.87 | 4.19 | 5.34 | 58.00 | 56.71 | 2.70 | 2.98 | 1.31 | 7.68 | 0.2082 | 42.75 | 1.80 | 2.12 | -21.37 | -18.49 | 5.95 | 2.71 |
| Draegerwerk AG & Co KGaA | 3.35bn | 113.44m | 790.27m | 16.56k | 6.83 | 0.5402 | 3.06 | 0.2361 | 6.05 | 6.05 | 178.45 | 76.45 | 1.11 | 2.47 | 4.97 | 205,014.40 | 3.80 | 3.26 | 5.61 | 4.87 | 43.51 | 44.16 | 3.41 | 3.05 | 1.10 | 6.83 | 0.1704 | 11.38 | 10.78 | 5.39 | 271.05 | 33.87 | 2.64 | 55.73 |
| GVS SpA | 433.30m | 17.36m | 892.50m | 4.39k | 50.95 | 2.54 | 14.33 | 2.06 | 0.1001 | 0.1001 | 2.48 | 2.01 | 0.4522 | 2.13 | 6.97 | 98,792.30 | 1.81 | 7.35 | 2.30 | 10.82 | 55.35 | 58.74 | 4.00 | 12.44 | 0.9776 | 3.51 | 0.5369 | -- | 9.58 | 15.25 | -43.37 | -9.97 | 16.08 | -- |
| El En SpA | 659.63m | 49.76m | 989.10m | 2.11k | 19.72 | 2.74 | 15.79 | 1.50 | 0.6223 | 0.6223 | 8.25 | 4.49 | 0.9141 | 1.77 | 3.69 | 316,823.50 | 7.02 | 7.43 | 12.89 | 13.52 | 40.03 | 38.83 | 7.68 | 7.63 | 1.19 | -- | 0.1845 | -- | 2.78 | 14.88 | -12.47 | 23.49 | -13.40 | -- |
| Biotage AB | 183.59m | 22.18m | 1.04bn | 675.00 | 47.08 | 3.17 | 27.62 | 5.69 | 3.21 | 3.21 | 26.56 | 47.60 | 0.4312 | 1.59 | 7.22 | 3,155,786.00 | 5.21 | 10.74 | 6.05 | 12.77 | 62.67 | 61.40 | 12.08 | 15.75 | 1.15 | 43.88 | 0.0616 | 40.11 | 19.54 | 15.50 | -8.21 | 7.97 | 14.05 | 1.30 |
| ChemoMetec A/S | 54.69m | 18.27m | 1.06bn | 173.00 | 57.74 | 13.92 | 51.10 | 19.29 | 7.83 | 7.83 | 23.44 | 32.48 | 0.6112 | 0.745 | 6.97 | 2,357,630.00 | 20.42 | 27.96 | 24.40 | 35.10 | 78.80 | 79.57 | 33.41 | 35.02 | 3.76 | -- | 0.0073 | 144.08 | -8.22 | 18.37 | -23.72 | 26.64 | 9.97 | -11.81 |
Data as of Nov 22 2024. Currency figures normalised to Paul Hartmann AG's reporting currency: Euro EUR
